ADAMTS13 and thrombotic thrombocytopenic purpura: And, a consistent subset of patients with severe ADAMTS13 deficiency (e.g. 29% in the series of 65 patients from the Oklahoma TTP-HUS Registry presented by JN George) has no neurological symptoms [23].